Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $13.62, but opened at $13.00. Oscar Health shares last traded at $14.09, with a volume of 30,791,723 shares.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on OSCR shares. Wall Street Zen cut shares of Oscar Health from a "buy" rating to a "hold" rating in a report on Sunday, June 8th. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Piper Sandler lowered Oscar Health from an "overweight" rating to a "neutral" rating and set a $14.00 price objective on the stock. in a report on Monday, July 14th. Robert W. Baird reissued a "neutral" rating and set a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a report on Friday. Finally, Barclays decreased their price target on shares of Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research note on Wednesday. Five research analysts have rated the stock with a sell rating and four have assigned a hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Reduce" and an average price target of $12.21.
Check Out Our Latest Research Report on Oscar Health
Oscar Health Price Performance
The company has a fifty day simple moving average of $16.05 and a two-hundred day simple moving average of $14.92. The stock has a market capitalization of $3.68 billion, a price-to-earnings ratio of 50.71 and a beta of 1.90. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88.
Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The business had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. During the same quarter in the previous year, the firm earned $0.62 earnings per share. Oscar Health's revenue for the quarter was up 42.2% compared to the same quarter last year. As a group, equities research analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.
Insider Activity at Oscar Health
In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director owned 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 24.39% of the company's stock.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Southeastern Asset Management Inc. TN boosted its stake in shares of Oscar Health by 52.2% in the 4th quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock valued at $42,082,000 after purchasing an additional 1,073,359 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its stake in Oscar Health by 37.8% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock valued at $23,403,000 after purchasing an additional 477,634 shares during the last quarter. Man Group plc boosted its position in Oscar Health by 344.8% in the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock valued at $24,370,000 after buying an additional 1,405,554 shares in the last quarter. Toronto Dominion Bank bought a new stake in shares of Oscar Health during the fourth quarter worth $1,008,000. Finally, Concurrent Investment Advisors LLC acquired a new position in shares of Oscar Health during the first quarter worth $677,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.
Oscar Health Company Profile
(
Get Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
Read More
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.